231 related articles for article (PubMed ID: 8993481)
1. Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.
DeKosky ST; Aston CE; Kamboh MI
Ann N Y Acad Sci; 1996 Dec; 802():27-34. PubMed ID: 8993481
[TBL] [Abstract][Full Text] [Related]
2. No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease.
Fallin D; Reading S; Schinka J; Hoyne J; Scibelli P; Gold M; Crawford F; Mullan M
Am J Med Genet; 1997 Apr; 74(2):192-4. PubMed ID: 9129722
[TBL] [Abstract][Full Text] [Related]
3. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
[TBL] [Abstract][Full Text] [Related]
4. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.
Murphy GM; Sullivan EV; Gallagher-Thompson D; Thompson LW; van Duijn CM; Forno LS; Ellis WG; Jagust WJ; Yesavage J; Tinklenberg JR
Neurology; 1997 May; 48(5):1313-6. PubMed ID: 9153464
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.
Licastro F; Pedrini S; Govoni M; Pession A; Ferri C; Annoni G; Casadei V; Veglia F; Bertolini S; Grimaldi LM
Neurosci Lett; 1999 Aug; 270(3):129-32. PubMed ID: 10462111
[TBL] [Abstract][Full Text] [Related]
6. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.
Lamb H; Christie J; Singleton AB; Leake A; Perry RH; Ince PG; McKeith IG; Melton LM; Edwardson JA; Morris CM
Neurology; 1998 Feb; 50(2):388-91. PubMed ID: 9484359
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease.
Nacmias B; Tedde A; Latorraca S; Piacentini S; Bracco L; Amaducci L; Guarnieri BM; Petruzzi C; Ortenzi L; Sorbi S
Ann Neurol; 1996 Oct; 40(4):678-80. PubMed ID: 8871590
[TBL] [Abstract][Full Text] [Related]
9. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N
Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173
[TBL] [Abstract][Full Text] [Related]
10. No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.
Helisalmi S; Mannermaa A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H
Neurosci Lett; 1997 Aug; 231(1):56-8. PubMed ID: 9280167
[TBL] [Abstract][Full Text] [Related]
11. Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.
Schwab SG; Bagli M; Papassotiropoulos A; Jessen F; Maier W; Rao ML; Heun R
Dement Geriatr Cogn Disord; 1999; 10(6):469-72. PubMed ID: 10559561
[TBL] [Abstract][Full Text] [Related]
12. Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease.
Yoshizawa T; Yamakawa-Kobayashi K; Hamaguchi H; Shoji S
J Neurol Sci; 1997 Nov; 152(2):136-9. PubMed ID: 9415533
[TBL] [Abstract][Full Text] [Related]
13. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
Didierjean O; Martinez M; Campion D; Hannequin D; Dubois B; Martin C; Puel M; Thomas Anterion C; Pasquier F; Moreau O; Babron MC; Penet C; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A
J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):103-5. PubMed ID: 9221977
[TBL] [Abstract][Full Text] [Related]
14. Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population.
Ezquerra M; Blesa R; Tolosa E; Ballesta F; Oliva R
Neurosci Lett; 1998 Jan; 240(2):107-9. PubMed ID: 9486483
[TBL] [Abstract][Full Text] [Related]
15. Genetic association between susceptibility to Parkinson's disease and alpha1-antichymotrypsin polymorphism.
Yamamoto M; Kondo I; Ogawa N; Asanuma M; Yamashita Y; Mizuno Y
Brain Res; 1997 Jun; 759(1):153-5. PubMed ID: 9219874
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon 4 of apolipoprotein E.
Müller U; Bödeker RH; Gerundt I; Kurz A
Neurology; 1996 Dec; 47(6):1575-7. PubMed ID: 8960749
[TBL] [Abstract][Full Text] [Related]
17. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.
Sweet RA; Kamboh MI; Wisniewski SR; Lopez OL; Klunk WE; Kaufer DI; DeKosky ST
J Geriatr Psychiatry Neurol; 2002; 15(1):24-30. PubMed ID: 11936240
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E: risk factor for Alzheimer disease.
Tsai MS; Tangalos EG; Petersen RC; Smith GE; Schaid DJ; Kokmen E; Ivnik RJ; Thibodeau SN
Am J Hum Genet; 1994 Apr; 54(4):643-9. PubMed ID: 8128961
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease.
Muramatsu T; Matsushita S; Arai H; Sasaki H; Higuchi S
J Neural Transm (Vienna); 1996; 103(10):1205-10. PubMed ID: 9013407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
